Cargando…

Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis

Detalles Bibliográficos
Autores principales:	Consuegra-Fernández, Marta, Isamat, Marcos, Lozano, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626862/ https://www.ncbi.nlm.nih.gov/pubmed/29033937 http://dx.doi.org/10.3389/fimmu.2017.01217

Ejemplares similares

Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance
por: Consuegra-Fernández, Marta, et al.
Publicado: (2017)

CD6 deficiency impairs early immune response to bacterial sepsis
por: Català, Cristina, et al.
Publicado: (2022)

Activation of Blood CD3(+)CD56(+)CD8(+) T Cells during Pregnancy and Multiple Sclerosis
por: de Andrés, Clara, et al.
Publicado: (2017)

Conserved Bacterial-Binding Peptides of the Scavenger-Like Human Lymphocyte Receptor CD6 Protect From Mouse Experimental Sepsis
por: Martínez-Florensa, Mario, et al.
Publicado: (2018)

Involvement of CD8(+) T Cells in Multiple Sclerosis
por: Salou, Marion, et al.
Publicado: (2015)

CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis
por: Sinha, Sushmita, et al.
Publicado: (2015)

Identification of CD137-Expressing B Cells in Multiple Sclerosis Which Secrete IL-6 Upon Engagement by CD137 Ligand
por: Wong, Hiu Yi, et al.
Publicado: (2020)

Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression
por: Peeters, Liesbet M., et al.
Publicado: (2017)

The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017)

Multifaceted effects of soluble human CD6 in experimental cancer models
por: Simões, Inês T, et al.
Publicado: (2020)

Commentary: Acute Hemorrhagic Leukoencephalitis (Weston–Hurst Syndrome) in a Patient with Relapse-Remitting Multiple Sclerosis
por: Koudriavtseva, Tatiana
Publicado: (2016)

Conservation of CD44 exon v3 functional elements in mammals
por: Vela, Elena, et al.
Publicado: (2008)

Loss of Circulating CD8+ CD161(high) T Cells in Primary Progressive Multiple Sclerosis
por: Acquaviva, Massimo, et al.
Publicado: (2019)

Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing–Remitting-Multiple Sclerosis Patients
por: D’Angelo, Chiara, et al.
Publicado: (2018)

Pathogenic CD8 T Cells in Multiple Sclerosis and Its Experimental Models
por: Huseby, Eric S., et al.
Publicado: (2012)

Vitamin D/CD46 Crosstalk in Human T Cells in Multiple Sclerosis
por: Killick, Justin, et al.
Publicado: (2020)

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
por: de Sèze, Jérôme, et al.
Publicado: (2023)

Fc multimers effectively treat murine models of multiple sclerosis
por: Wang, Jin, et al.
Publicado: (2023)

Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement
por: Charvet, Benjamin, et al.
Publicado: (2018)

Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells
por: Tilly, Gaëlle, et al.
Publicado: (2021)

Editorial: Brain-Targeted Autoimmunity: Beyond Multiple Sclerosis
por: Nataf, Serge, et al.
Publicado: (2021)

Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
por: Liu, Rongzeng, et al.
Publicado: (2022)

Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis
por: Lundström, Wangko, et al.
Publicado: (2022)

Potential biological contributers to the sex difference in multiple sclerosis progression
por: Alvarez-Sanchez, Nuria, et al.
Publicado: (2023)

Case Report: Adult Still’s Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient
por: Krämer, Julia, et al.
Publicado: (2020)

Commentary: The Scavenger Receptor SSc5D Physically Interacts with Bacteria through the SRCR-Containing N-Terminal Domain
por: Lozano, Francisco, et al.
Publicado: (2017)

Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis
por: Koudriavtseva, Tatiana, et al.
Publicado: (2023)

Corrigendum: Commentary: The Scavenger Receptor SSc5D Physically Interacts with Bacteria through the SRCR-Containing N-Terminal Domain
por: Lozano, Francisco, et al.
Publicado: (2017)

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis
por: Li, Rui, et al.
Publicado: (2016)

B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers
por: van Langelaar, Jamie, et al.
Publicado: (2020)

SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
por: MacDougall, Madison, et al.
Publicado: (2022)

Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis
por: Akgün, Katja, et al.
Publicado: (2020)

Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets
por: Giovannoni, Gavin, et al.
Publicado: (2021)

MicroRNAs of Human Herpesvirus 6A and 6B in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
por: Domínguez-Mozo, María I., et al.
Publicado: (2020)

Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4(+) T Cells in Multiple Sclerosis
por: Faigle, Wolfgang, et al.
Publicado: (2019)

Mass Cytometry Identifies Expansion of T-bet(+) B Cells and CD206(+) Monocytes in Early Multiple Sclerosis
por: Couloume, Laura, et al.
Publicado: (2021)

Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis
por: Liu, Pen-Ju, et al.
Publicado: (2023)

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018)

Targeting Phosphodiesterases—Towards a Tailor-Made Approach in Multiple Sclerosis Treatment
por: Schepers, Melissa, et al.
Publicado: (2019)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
por: Xavier, Alexandre, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lg2kn1083jobmu0qeaid20qcfu